CML-HMGB1 and HMGB1—and the sum of both—were found to be expressed at higher levels in the insensitive group (grade 0–1a) than in the sensitive group (grade 1b–2). Here, HMGB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.